Stanford University Team Wins Award for Drug-Delivery Catheter Design - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Stanford University Team Wins Award for Drug-Delivery Catheter Design


The Wyshbone drug-delivery catheter, which continuously applies lidocaine to the throat during breathing tube insertion, won second prize last week in the National Collegiate Inventors and Innovators Alliance (NCIIA) Biomedical Engineering Innovation, Design, and Entrepreneurship Award (BMEidea) contest, NCIIA announced in a press release. The targeted drug-delivery approach allows clinicians to minimize sedation and its accompanying side effects.

Rush Bartlett II, PhD, and Ryan Van Wert, MD, designed the device as part of their participation in Stanford’s Biodesign Program, which places fellows in a local hospital to identify medical or operational problems and build prototypes to provide solutions. Bartlett and Van Wert founded medical-device start-up AWAIR, which received initial funding from NCIIA.

The NCIIA helps student and faculty entrepreneurs bring concepts to commercialization. BMEidea is an annual competition with awards presented each year at the MD&M East Medical Device Trade Show and Convention. 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here